Topic

BCMA CD3 T-cell engager

1 article

Pfizer Launches Bispecific Antibody Elranatamab in India for Advanced Multiple Myeloma
News 3 Jun 2026

Pfizer Launches Bispecific Antibody Elranatamab in India for Advanced Multiple Myeloma

Pfizer has announced the commercial launch of its bispecific antibody elranatamab in India for the treatment of adults with relapsed…